CommentNeed for improved global measurement of early childhood respiratory syncytial virus disease
References (8)
- et al.
The respiratory syncytial virus landscape: lessons from the graveyard and promising candidates
Lancet Infect Dis
(2018) - et al.
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study
Lancet
(2017) - et al.
Health and economic burden of respiratory syncytial virus (RSV) disease and the cost-effectiveness of potential interventions against RSV among children under 5 years in 72 Gavi-eligible countries
BMC Med
(2020) Meeting of the Strategic Advisory Group of Experts on Immunization, April 2016—conclusions and recommendations
Wkly Epidemiol Rec
(2016)
There are more references available in the full text version of this article.
Cited by (3)
Volatility of the COVID-19 vaccine hesitancy: sentiment analysis conducted in Brazil
2023, Frontiers in Public Health
© 2022 Elsevier Ltd. All rights reserved.